Corporate Social Responsibility
Adhere To The Principle Of Sustainable Development To Create A Better Life
Product Quality and Safety
Product quality is the foundation of Joincare’s steady growth. We are committed to delivering high-quality products and services to our customers by continuously enhancing our comprehensive quality management system throughout the product lifecycle—from R&D and development to post-market patient use. We strengthen supply chain management to ensure the quality of raw materials, and adhere to responsible marketing principles to promote our products with accuracy and integrity, safeguarding public health with unwavering dedication.
Quality Management System
We have established and continuously refined a full-lifecycle quality management system that covers drug development, manufacturing, marketing, and use. In proactive response to regulatory requirements, we diligently fulfill our responsibilities as the marketing authorization holder, striving to provide patients with high-quality and reliable products.
Certification of the Quality Management System
Name
Certification
Joincare
GB/T19001-2016/ISO 9001:2015；ISO/IEC 17025:2017/CNAS-CL01
Joincare Haibin
GB/T19001-2016/ISO 9001:2015
Jiaozuo Joincare
GB/T19001-2016/ISO 9001:2015
Fuzhou Fuxing
GB/T19001-2016/ISO 9001:2015
Ningxia Pharmaceutical
GB/T19001-2016/ISO 9001:2015；ISO 22000:2018
Livzon Diagnostics
GB/T42061-2022/ISO 13485:2016
Shanghai Frontier
GB/T19001-2016/ISO 9001:2015；CNAS - CL01:2018
Haibin Pharma
CNAS-CL01:2018
Quality Training for Employees
Joincare places great emphasis on product quality training and awareness. We have established a quality training management procedure and developed an annual training plan covering all employees. Through diverse formats such as micro-courses, interactive events, online knowledge challenges, and skills competitions, we continuously enhance employees’ capabilities and awareness in quality management.
100
%
Quality training coverage
730
+ times
Quality-related training sessions during 2024
47.37
hours
Average hours of quality-related training during 2024
Product Quality and Safety Objectives
Joincare is committed to the continuous improvement of its quality management system, the refinement of operational mechanisms, and the enhancement of quality monitoring capabilities. We have established overall corporate quality objectives and conduct ongoing annual reviews of their achievement. Key targets include:
100
%
Pass rate in Market sampling
1
%
Customer complaint rate below
90
%
Customer satisfaction rate above
Supply Chain Management
Joincare actively collaborates with suppliers to build harmonious and mutually beneficial partnerships, ensuring supply chain stability and sustainable development.
Supplier Classification and Risk Management
During the supplier evaluation and management process, we prioritize comprehensive identification, assessment, and control of supply chain risks. Evaluation dimensions include Environmental, Social, and Governance (ESG) impacts as well as business relevance. For ESG-related risks, we conduct assessments across three levels—country risk, sector-specific risk, and product-specific risk—to identify our key suppliers and critical indirect suppliers.
Enterprise Qualifications
Enterprise Financial Status
Enterprise Business Environment
Enterprise Product Quality And Service
Impact Of Environment And Other EHS
Impact Of National Environmental Protection Regulations And Policies
Impact Of Unusual Climate
International Trade Environment And Impact
Impact Of International Finance And Exchange Rate
Impact Of Major Unexpected Events
Impact Of Social Events
Impact Of Festivals
Impact Of Business Ethics
Impact Of Workers’ Human Rights
Dimension of supply chain risk assessment
Supply Chain Risk Mitigation Plan
To ensure production stability and product quality and safety, we have developed comprehensive and systematic risk mitigation strategies and contingency plans tailored to our supply chain and business operations.
In the procurement stage, we have established and continuously improved a dual-sourcing system and implemented policies for alternative suppliers. For raw materials, excipients, and key consumables, we maintain backup supplier options to mitigate the risk of supply disruptions.
In the manufacturing stage, we integrate formulation development with the establishment of API production bases, actively advancing API manufacturing processes to enhance in-house production capabilities—aiming to achieve integrated “API + formulation” manufacturing. In addition, our multiple production facilities across China serve as mutual backup sites, enabling production support in the event of emergencies.
We closely monitor the inventory levels of production materials and have implemented a series of risk response measures to safeguard production stability at the source. Subsidiaries also proactively adopt measures to address supply chain stability risks.
Case: Active response to risks posing to supply chain stability at Joincare Haibin
The company ensures that its main raw materials and packaging materials are purchased from multiple suppliers, and production consumables are chosen from a number of qualified suppliers, in order to avoid supply shortage and enhance stability. In 2024, the company engaged several new suppliers. When existing suppliers experienced short-term supply shortage due to force majeure, the new suppliers would be able to provide sufficient supply in a timely manner. This practice prevented production interruption and reduced the risk of supply disruption of raw materials and excipients as well as packaging materials by approximately 40%.
The company plans to introduce domestic suppliers for exclusive imported materials, striving to mitigate risks such as delayed delivery due to the change of the international pattern or suppliers' own reasons. In 2024, the company developed domestic suppliers. After several rounds of strict selection and quality assessment, Joincare Haibin selected those with excellent qualifications and strong technical strengths to enrich the supply source. This helped mitigate the overseas supply risks caused by international trade friction.
Case:Taitai Pharmaceutical ensures supply chain stability
Taitai Pharmaceutical has reviewed past cooperation patterns with suppliers and devised feasible solutions to mitigate supply risks. These solutions aim to address material shortages, supply interruptions, delays in delivery and other potential risks to supply chain stability:
The company regularly checks its inventory, establishes the minimum inventory alert line, and makes preparations for material purchase in advance.
The company regularly conducts desk assessment or on-site audit of suppliers’ qualifications and production sites to understand their latest operating status, and timely assists suppliers to solve difficulties in production.
The company establishes long-term cooperation with suppliers and signs annual procurement agreements to ensure that suppliers deliver according to requirements and to reduce the risk of supply interruption.
In 2024, Taitai Pharmaceutical further introduced 12 qualified suppliers to phase in the dual-supplier mechanism for all raw materials, excipients and key consumables. This effort ensured the stable supply of raw materials along the production line and avoided production stagnation due to raw material shortage. As a result, the company firmly guaranteed the continuity of production and reinforced resistance to risks during procurement.
Supplier ESG Management
Joincare systematically implements ESG management for suppliers, with continuous attention to their sustainability practices and performance. The Group’s Sustainability Committee under the Board of Directors serves as the highest decision-making body, responsible for overseeing the implementation of supplier ESG management.
We have clearly defined ESG expectations for suppliers in the Supplier Code of Conduct, and we emphasize ESG performance throughout key processes such as onboarding, audits, and evaluations.
Case: Joincare’s subsidiaries conducted supplier training
In 2024, Joincare Haibin provided quality enhancement training for all high-risk material suppliers, communicating the Group’s quality management goals to suppliers, and helping them better understand the key points of quality and EHS management.
In 2024, Haibin Pharma provided 18 quality training sessions for suppliers, communicating the Group’s quality management requirements to suppliers, and strengthening their awareness of quality management.
In 2024, Jiaozuo Joincare launched a series of systematic and targeted quality training activities for raw material suppliers, mainly centring on three topics of “How to promote 5s management”, “ISO9001 quality management system standards”, and “How to carry out on-site QA management”. These activities aimed to maintain quality and stable raw material supply, thus laying a solid foundation for product quality. The company also actively supports suppliers in improving their own supplier management level, and helps them stay complaint with regulatory requirements and build robust supplier management processes to ensure the quality and safety of materials from the source.
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.